Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations

NCT00891579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed (Alimta)
DRUG: Gefitinib (IRESSA)

Sponsor

Chinese Society of Lung Cancer